Marc-André Champigny Marc-André Champigny

Medici Technologies Inc. (dba Livewell) in its sale to Hims & Hers

On December 4, 2025, Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, announced its expansion into Canada through its acquisition of Medici Technologies Inc. (dba Livewell). Livewell is a trusted Canadian digital health platform focused...

Lead Office: Montreal Date Announced: December 4, 2025 Value: --

Two Small Fish Ventures in connection with ENVGO’s US$2-million financing round

On June 10, 2025, ENVGO announced that it raised US$2 million in an all-equity round led by Two Small Fish Ventures.  The company plans on utilizing the funding towards bringing its product to the market. Two Small Fish Ventures, founded in 2014 as an angel investment group, is a...

Lead Office: Toronto Date Announced: June 10, 2025 Value: US$2 million

Deep Sky in its securing of US$40-million grant from Breakthrough Energy Catalyst

On December 18, 2024, Deep Sky announced it secured a US$40-million grant from Breakthrough Energy Catalyst. These funds will be utilized towards research and testing of direct air capture technologies. It is noted that this is Breakthrough Energy Catalyst's first-ever investment in both a...

Lead Office: Montreal Date Announced: December 18, 2024 Value: US$40 million

Deck Software in its raising of $6.2 million of Seed financing

On October 15, 2024, Deck Software announced that it raised $6.2 million in a Seed financing round. This all-equity, all-primary round was co-led by Golden Ventures and Better Tomorrow Ventures. This round also saw participation from Luge Capital. Deck Software is a new application programming...

Lead Office: Toronto Date Announced: October 15, 2024 Value: $6.2 million

Motion Creative Cloud in its raising of US$30-million Series B financing

On September 19, 2024, Motion Creative Cloud announced its raising of US$30 million in a Series B financing round. This round was led by Inovia Capital and saw participation from Threshold Ventures and other existing investors including Silicon Valley investors: Headline, Abstract Ventures and...

Lead Office: Toronto Date Announced: September 19, 2024 Value: US$30 million

Inversago Pharma in its US$1.075 billion business combination with Novo Nordisk

On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075 billion pursuant to the completion of certain development and commercial milestones. This acquisition will strengthen Nova Nordisk’s clinical development and research capability for obesity and...

Lead Office: Montreal Date Closed: -- Value: US$1.075 billion